To further delineate the role of the ZEB1/CXCL16 axis in CD8+ T cell activity and the sensitivity of PC tumors to chemoimmunotherapy or T cell therapy, we investigated CD8+ T cell functions. The gene discussed is CXCL16; the disease is pachyonychia congenita.